Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Role and regulation of the thrombin receptor (PAR-1) in human melanoma

Oncogene volume 22, pages 3130–3137 (2003)Cite this article

Abstract

To determine treatment strategies and predict the clinical outcome of patients with melanoma it is important to understand the etiology of this disease. Recently, there has been some insight into molecular basis of melanoma including identification of a few of the regulatory factors and genes involved in this disease. For instance, the transcription factor AP-2 plays a tumor suppressor-like role in melanoma progression by regulating genes involved in tumor growth and metastasis. Previously, we have shown that the progression of human melanoma to the metastatic phenotype is associated with loss of AP-2 expression and deregulation of target genes such as MUC18/MCAM, c-KIT, and MMP-2. Increasing evidence demonstrates that the thrombin receptor (protease-activated receptor-1, PAR-1) plays a major role in tumor invasion and contributes to the metastatic phenotype of human melanoma. This review focuses on the role of the thrombin receptor in melanoma and its regulation by AP-2. We show that loss of AP-2 expression in metastatic melanoma cells correlates with overexpression of the thrombin receptor. Our analysis of AP-2/Sp1 complexes within the regulatory region of the thrombin receptor demonstrates that AP-2 binds the proximal 3′ region of the promoter and diminishes PAR-1 expression. Levels of AP-2 and Sp1 proteins in a panel of melanoma cell lines demonstrated a marked decrease in the ratio of AP-2/Sp1, a decrease that correlated with overexpression of PAR-1 in metastatic melanoma cells. We propose that loss of AP-2 results in increased expression of the thrombin receptor, which subsequently contributes to the metastatic phenotype of melanoma by upregulating the expression of adhesion molecules, proteases, and angiogenic molecules.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Baldi A, Santini D, Battista T, Dragonetti E, Ferranti G, Petitti T, Groeger AM, Angelini A, Rossiello R, Baldi F, Natali PG and Paggi MG . (2001). J. Cell. Biochem., 83, 364–372.

  • Bar-Eli M . (2001). Pigment Cell Res., 14, 78–85.

  • Batsche E, Muchardt C, Behrens J, Hurst HC and Cremisi C . (1998). Mol. Cell. Biol., 18, 3647–3658.

  • Bauer R, Imhof A, Pscherer A, Kopp H, Moser M, Seegers S, Kerscher M, Tainsky MA, Hofstaedter F and Buettner R . (1994). Nucleic Acids Res., 22, 1413–1420.

  • Bohm M, Moellmann G, Cheng E, Alvarez-Franco M, Wagner S, Sassone-Corsi P and Halaban R . (1995). Cell Growth Differ., 6, 291–302.

  • Bosher JM, Williams T and Hurst HC . (1995). Proc. Natl. Acad. Sci. USA, 92, 744–747.

  • Brach MA, Kauer M and Herrmann F . (1996). Cytokines Mol. Ther., 2, 81–87.

  • Bromberg ME, Konigsberg WH, Madison JF, Pawashe A and Garen A . (1995). Proc. Natl. Acad. Sci. USA, 92, 8205–8209.

  • Buettner R, Kannan P, Imhof A, Bauer R, Yim SO, Glockshuber R, Van Dyke MW and Tainsky MA . (1993). Mol. Cell. Biol., 13, 4174–4185.

  • Carmeliet P and Jain RK . (2000). Nature, 407, 249–257.

  • Chen TT, Wu RL, Castro-Munozledo F and Sun TT . (1997). Mol. Cell. Biol., 17, 3056–3064.

  • Cucina A, Borrelli V, Di Carlo A, Pagliei S, Corvino V, Santoro-D'Angelo L, Cavallaro A and Sterpetti AV . (1999). J. Surg. Res., 82, 61–66.

  • Degen SJ and Sun WY . (1998). Crit. Rev. Eukaryot. Gene. Expr., 8, 203–224.

  • Descheemaeker KA, Wyns S, Nelles L, Auwerx J, Ny T and Collen D . (1992). J. Biol. Chem., 267, 15086–15091.

  • Duan C and Clemmons DR . (1995). J. Biol. Chem., 270, 24844–24851.

  • Esumi N, Fan D and Fidler IJ . (1991). Cancer Res., 51, 4549–4556.

  • Even-Ram S, Uziely B, Cohen P, Grisaru-Granovsky S, Maoz M, Ginzburg Y, Reich R, Vlodavsky I and Bar-Shavit R . (1998). Nat. Med., 4, 909–914.

  • Even-Ram SC, Maoz M, Pokroy E, Reich R, Katz BZ, Gutwein P, Altevogt P and Bar-Shavit R . (2001). J. Biol. Chem., 276, 10952–10962.

  • Fenton II JW . (1988). Semin. Thromb. Hemost., 14, 234–240.

  • Fischer EG, Ruf W and Mueller BM . (1995). Cancer Res., 55, 1629–1632.

  • Folkman J . (1971). N. Engl. J. Med., 285, 1182–1186.

  • Gaubatz S, Imhof A, Dosch R, Werner O, Mitchell P, Buettner R and Eilers M . (1995). EMBO J., 14, 1508–1519.

  • Gaynor RB, Muchardt C, Xia YR, Klisak I, Mohandas T, Sparkes RS and Lusis AJ . (1991). Genomics, 10, 1100–1102.

  • Gee JM, Robertson JF, Ellis IO, Nicholson RI and Hurst HC . (1999). J. Pathol., 189, 514–520.

  • Gershenwald JE, Sumner W, Calderone T, Wang Z, Huang S and Bar-Eli M . (2001). Oncogene, 20, 3363–3375.

  • Getman DK, Mutero A, Inoue K and Taylor P . (1995). J. Biol. Chem., 270, 23511–23519.

  • Gille J, Reisinger K, Asbe-Vollkopf A, Hardt-Weinelt K and Kaufmann R . (2000). J. Invest. Dermatol., 115, 30–36.

  • Gille J, Swerlick RA and Caughman SW . (1997). EMBO J., 16, 750–759.

  • Goding CR . (2000). Genes Dev., 14, 1712–1728.

  • Grand RJ, Turnell AS and Grabham PW . (1996). Biochem. J., 313, 353–368.

  • Grether-Beck S, Olaizola-Horn S, Schmitt H, Grewe M, Jahnke A, Johnson JP, Briviba K, Sies H and Krutmann J . (1996). Proc. Natl. Acad. Sci. USA, 93, 14586–14591.

  • Haslinger A and Karin M . (1985). Proc. Natl. Acad. Sci. USA, 82, 8572–8576.

  • Henrikson KP, Salazar SL, Fenton II JW and Pentecost BT . (1999). Br. J. Cancer, 79, 401–416.

  • Hollywood DP and Hurst HC . (1993). EMBO J., 12, 2369–2375.

  • Huang S, DeGuzman A, Bucana CD and Fidler IJ . (2000). Clin. Cancer Res., 6, 2573–2581.

  • Huang S, Jean D, Luca M, Tainsky MA and Bar-Eli M . (1998). EMBO J., 17, 4358–4369.

  • Huang Y and Domann FE . (1998). Biochem. Biophys. Res. Commun., 249, 307–312.

  • Huang YQ, Li JJ, Hu L, Lee M and Karpatkin S . (2001). Thromb. Haemost., 86, 1094–1098.

  • Hyman SE, Comb M, Pearlberg J and Goodman HM . (1989). Mol. Cell. Biol., 9, 321–324.

  • Imagawa M, Chiu R and Karin M . (1987). Cell, 51, 251–260.

  • Jean D, Gershenwald JE, Huang S, Luca M, Hudson MJ, Tainsky MA and Bar-Eli M . (1998a). J. Biol. Chem., 273, 16501–16508.

  • Jean D, Harbison M, McConkey DJ, Ronai Z and Bar-Eli M . (1998b). J. Biol. Chem., 273, 24884–24890.

  • Jean D, Tellez C, Huang S, Davis DW, Bruns CJ, McConkey DJ, Hinrichs SH and Bar-Eli M . (2000). Oncogene, 19, 2721–2730.

  • Jiang JG, DeFrances MC, Machen J, Johnson C and Zarnegar R . (2000). Biochem. Biophys. Res. Commun., 272, 882–886.

  • Jiang MS and Lane MD . (2000). Proc. Natl. Acad. Sci. USA, 97, 12519–12523.

  • Kanno M, Fromental C, Staub A, Ruffenach F, Davidson I and Chambon P . (1989). EMBO J., 8, 4205–4214.

  • Karjalainen JM, Kellokoski JK, Eskelinen MJ, Alhava EM and Kosma VM . (1998). J. Clin. Oncol., 16, 3584–3591.

  • Kaufmann R, Schafberg H, Rudroff C and Nowak G . (1997). Cancer, 80, 2068–2074.

  • Kerbel RS . (2000). Carcinogenesis, 21, 505–515.

  • King R, Weilbaecher KN, McGill G, Cooley E, Mihm M and Fisher DE . (1999). Am J. Pathol., 155, 731–738.

  • Leask A, Byrne C and Fuchs E . (1991). Proc. Natl. Acad. Sci. USA, 88, 7948–7952.

  • Lebeau B, Chastang C, Brechot JM, Capron F, Dautzenberg B, Delaisements C, Mornet M, Brun J, Hurdebourcq JP and Lemarie E . (1994). Cancer, 74, 38–45.

  • Lee W, Haslinger A, Karin M and Tjian R . (1987). Nature, 325, 368–372.

  • Li F, Baykal D, Horaist C, Yan CN, Carr BN, Rao GN and Runge MS . (1996). J. Biol. Chem., 271, 26320–26328.

  • Liu CY, Nossel HL and Kaplan KL . (1979). J. Biol. Chem., 254, 10421–10425.

  • Liu Y, Gilcrease MZ, Henderson Y, Yuan XH, Clayman GL and Chen Z . (2001). Cancer Lett., 169, 173–180.

  • Lombardi A, De Simone G, Galdiero S, Staiano N, Nastri F and Pavone V . (1999). Biopolymers, 51, 19–39.

  • Luca MR and Bar-Eli M . (1998). Histol. Histopathol., 13, 1225–1231.

  • Luscher B, Mitchell PJ, Williams T and Tjian R . (1989). Genes Dev., 3, 1507–1517.

  • Macfarlane SR, Seatter MJ, Kanke T, Hunter GD and Plevin R . (2001). Pharmacol. Rev., 53, 245–282.

  • Meier F, Satyamoorthy K, Nesbit M, Hsu MY, Schittek B, Garbe C and Herlyn M . (1998). Front Biosci., 3, D1005–D1010.

  • Mitchell PJ, Timmons PM, Hebert JM, Rigby PW and Tjian R . (1991). Genes Dev., 5, 105–119.

  • Mitchell PJ, Wang C and Tjian R . (1987). Cell, 50, 847–861.

  • Mueller BM, Reisfeld RA, Edgington TS and Ruf W . (1992). Proc. Natl. Acad. Sci. USA, 89, 11832–11836.

  • Nierodzik ML, Chen K, Takeshita K, Li JJ, Huang YQ, Feng XS, D'Andrea MR, Andrade-Gordon P and Karpatkin S . (1998). Blood, 92, 3694–3700.

  • Nottoli T, Hagopian-Donaldson S, Zhang J, Perkins A and Williams T . (1998). Proc. Natl. Acad. Sci. USA, 95, 13714–13719.

  • Nyborg JK and Dynan WS . (1990). J. Biol. Chem., 265, 8230–8236.

  • Ornstein DL and Zacharski LR . (1999). Haemostasis, 29(Suppl S1), 48–60.

  • Ornstein DL and Zacharski LR . (2001). Int. J. Hematol., 73, 157–161.

  • Poser I, Dominguez D, de Herreros AG, Varnai A, Buettner R and Bosserhoff AK . (2001). J. Biol. Chem., 276, 24661–24666.

  • Richard DE, Vouret-Craviari V and Pouyssegur J . (2001). Oncogene, 20, 1556–1562.

  • Ropponen KM, Kellokoski JK, Lipponen PK, Pietilainen T, Eskelinen MJ, Alhava EM and Kosma VM . (1999). Br. J. Cancer, 81, 133–140.

  • Rudroff C, Schafberg H, Nowak G, Weinel R, Scheele J and Kaufmann R . (1998). Pancreas, 16, 189–194.

  • Ruiz M, Troncoso P, Bruns C and Bar-Eli M . (2001). Clin. Cancer Res., 7, 4086–4095.

  • Rutberg SE, Goldstein IM, Yang YM, Stackpole CW and Ronai Z . (1994). Mol. Carcinog., 10, 82–87.

  • Schmidt VA, Vitale E and Bahou WF . (1996). J. Biol. Chem., 271, 9307–9312.

  • Schorle H, Meier P, Buchert M, Jaenisch R and Mitchell PJ . (1996). Nature, 381, 235–238.

  • Senger DR, Ledbetter SR, Claffey KP, Papadopoulos-Sergiou A, Peruzzi CA and Detmar M . (1996). Am. J. Pathol., 149, 293–305.

  • Shimizu S, Gabazza EC, Hayashi T, Ido M, Adachi Y and Suzuki K . (2000). Am. J. Physiol. Lung Cell. Mol. Physiol., 279, L503–L510.

  • Tapparelli C, Metternich R, Ehrhardt C and Cook NS . (1993). Trends Pharmacol. Sci., 14, 366–376.

  • Thornes RD, Daly L, Lynch G, Breslin B, Browne H, Browne HY, Corrigan T, Daly P, Edwards G, Gaffney E et al. (1994). J. Cancer Res. Clin. Oncol., 120(Suppl), S32–S34.

  • Turner BC, Zhang J, Gumbs AA, Maher MG, Kaplan L, Carter D, Glazer PM, Hurst HC, Haffty BG and Williams T . (1998). Cancer Res., 58, 5466–5472.

  • Ueno A, Murakami K, Yamanouchi K, Watanabe M and Kondo T . (1996). Immunology, 88, 76–81.

  • Vouret-Craviari V, Van Obberghen-Schilling E, Rasmussen UB, Pavirani A, Lecocq JP and Pouyssegur J . (1992). Mol. Biol. Cell., 3, 95–102.

  • Vu TK, Hung DT, Wheaton VI and Coughlin SR . (1991). Cell, 64, 1057–1068.

  • Wang D, Shin TH and Kudlow JE . (1997). J. Biol. Chem., 272, 14244–14250.

  • Weitz JI, Hudoba M, Massel D, Maraganore J and Hirsh J . (1990). J. Clin. Invest., 86, 385–391.

  • Williams T, Admon A, Luscher B and Tjian R . (1988). Genes Dev., 2, 1557–1569.

  • Williams T and Tjian R . (1991). Science, 251, 1067–1071.

  • Wojtukiewicz MZ, Tang DG, Ben-Josef E, Renaud C, Walz DA and Honn KV . (1995). Cancer Res., 55, 698–704.

  • Wojtukiewicz MZ, Tang DG, Ciarelli JJ, Nelson KK, Walz DA, Diglio CA, Mammen EF and Honn KV . (1993). Int. J. Cancer, 54, 793–806.

  • Wojtukiewicz MZ, Tang DG, Nelson KK, Walz DA, Diglio CA and Honn KV . (1992). Thromb. Res., 68, 233–245.

  • Wojtukiewicz MZ, Zacharski LR, Memoli VA, Kisiel W, Kudryk BJ, Rousseau SM and Stump DC . (1990). Am. J. Clin. Pathol., 93, 516–521.

  • Xie S, Price JE, Luca M, Jean D, Ronai Z and Bar-Eli M . (1997). Oncogene, 15, 2069–2075.

  • Yeh CC, Wan XS and St Clair DK . (1998). DNA Cell Biol., 17, 921–930.

  • Yoshida E, Verrusio EN, Mihara H, Oh D and Kwaan HC . (1994). Cancer Res., 54, 3300–3304.

  • Zacharski LR, Memoli VA, Morain WD, Schlaeppi JM and Rousseau SM . (1995). Thromb. Haemost., 73, 793–797.

  • Zeng YX, Somasundaram K and El-Deiry WS . (1997). Nat. Genet., 15, 78–82.

  • Zhang J, Hagopian-Donaldson S, Serbedzija G, Elsemore J, Plehn-Dujowich D, McMahon AP, Flavell RA and Williams T . (1996). Nature, 381, 238–241.

  • Zhu CH, Huang Y, Oberley LW and Domann FE . (2001). J. Biol. Chem., 276, 14407–14413.

  • Zucker S, Conner C, DiMassmo BI, Ende H, Drews M, Seiki M and Bahou WF . (1995). J. Biol. Chem., 270, 23730–23738.

Download references

Acknowledgements

We thank Mr Walter Pagel for expert scientific editing of the manuscript. This work was supported by the National Institutes of Health Grant CA76098.

Author information

Authors and Affiliations

  1. Department of Cancer Biology, The University of Texas M.D. Anderson Cancer Center, Houston, 77030, TX, USA

    Carmen Tellez & Menashe Bar-Eli

Authors
  1. Carmen Tellez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Menashe Bar-Eli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Menashe Bar-Eli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tellez, C., Bar-Eli, M. Role and regulation of the thrombin receptor (PAR-1) in human melanoma. Oncogene 22, 3130–3137 (2003). https://doi.org/10.1038/sj.onc.1206453

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206453

Keywords

This article is cited by

Search

Advanced search

Quick links